13,139 resources
Start Prev Rows 8400 - 8600 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| hl7.fhir.us.breastcancer | R3 | oncology-ProgesteroneReceptorInterpretationTestsVS | BC ProgesteroneReceptorInterpretationTestsVS ValueSet | draft | 2018-08 | hl7 | loinc | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1003 | Observation Method | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8037 | Test Type (Brucellosis) | active | 2021-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3097 | Present Absent Unknown Not Examined | active | 2008-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7612 | Late Clinical Manifestation (STD) | active | 2021-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.883 | PHIN Questions | active | 2013-01 | oid | |||
| signal.core.r4 | R4 | questionnaire-ccars-legal-status | Questionnaire CCARS Legal Status | draft | 1 | pa | hl7 | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7714 | Legionella Diagnosis (RIBD) | active | 2018-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7715 | Legionella Exposure (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7737 | Legionellosis Serogroup (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7770 | Length of Time Drug Taken (TB) | active | 2018-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7468 | Length of Gestation in Weeks | active | 2016-01 | sct | |||
| hl7.fhir.us.registry-protocols | R4 | LesionSegmentNumber | Lesion Segment Number | active | cic | 2023-11 | hl7 | fhir sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.921 | Emergency Department Acuity | active | 2008-01 | tho oid | |||
| hl7.fhir.us.mcode | R4 | mcode-clark-level-value-vs | Clark Level Value Set | active | cic | 2025-02 | hl7 | sct | |
| signal.core.r4 | R4 | questionnaire-answers-status | QuestionnaireResponseStatus | draft | 3 | fhir | 2019-10 | hl7 | fhir |
| hl7.fhir.us.mcode | R4 | mcode-tnm-distant-metastases-staging-type-max-vs | TNM Distant Metastases Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | hl7 | fhir loinc |
| hl7.fhir.us.mcode | R4 | mcode-tnm-primary-tumor-staging-type-max-vs | TNM Primary Tumor Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | hl7 | fhir loinc |
| hl7.fhir.us.mcode | R4 | mcode-tnm-regional-nodes-staging-type-max-vs | TNM Regional Nodes Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | hl7 | fhir loinc |
| hl7.fhir.us.mcode | R4 | mcode-tnm-stage-group-staging-type-max-vs | TNM Stage Group Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | hl7 | fhir loinc |
| hl7.fhir.us.mcode | R4 | mcode-condition-status-trend-max-vs | Condition Status Trend Maximum Value Set | active | 3 | cic | 2025-02 | hl7 | fhir sct |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.941 | Susceptibility Result | active | 2008-01 | sct tho oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.636 | Lp(a) Test_CPT | active | 2025-03 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.637 | LP(a) Test | active | 2025-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.634 | Lp(a) Test_LOINC | active | 2025-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.633 | Lp(a) Test_SNOMED | active | 2025-03 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3241 | Notifiable Event Condition (Flu) | active | 2009-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3594 | Campylobacter Organism | active | 2010-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.988 | Countermeasure Encounter Purpose | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.989 | Countermeasure Encounter Type | active | 2008-01 | tho | |||
| hl7.fhir.us.resp-net | R4 | resp-net-labtest-covid-codes | resp-net-labtest-covid-codes | draft | 2025-08 | hl7 | cpt loinc | ||
| hl7.fhir.us.resp-net | R4 | resp-net-labtest-flu-codes | resp-net-labtest-flu-codes | draft | 2025-08 | hl7 | cpt loinc | ||
| hl7.fhir.us.resp-net | R4 | resp-net-labtest-flu-rsv-covid-codes | resp-net-labtest-flu-rsv-covid-codes | draft | 2025-08 | hl7 | cpt loinc | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6047 | Message Structure (Syndromic Surveillance) | active | 2019-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3244 | Medication Treatment (Flu) | active | 2009-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1073 | Microbiology Test Result Name | active | 2008-01 | loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1107 | Notification Section Header | active | 2015-01 | oid loinc | |||
| hl7.fhir.us.resp-net | R4 | resp-net-labtest-rsv-codes | resp-net-labtest-rsv-codes | draft | 2025-08 | hl7 | cpt loinc | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6048 | Event Type (Syndromic Surveillance) | active | 2012-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6049 | Message Type (Syndromic Surveillance) | active | 2019-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6050 | Universal ID Type (Syndromic Surveillance) | active | 2012-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8012 | Activity Type (Brucellosis) | active | 2021-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3502 | Infectious Disease | active | 2010-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3501 | Bacterial Infectious Disease | active | 2010-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3503 | Pneumonia Disease | active | 2010-01 | sct | |||
| hl7.fhir.us.davinci-crd | R4 | cardType | CRD Card Types Value Set | trial-use | 4 | fm | 2025-08 | hl7 | fhir |
| hl7.fhir.us.resp-net | R4 | resp-net-positive-result-codes | resp-net-positive-result-codes | draft | 2025-08 | hl7 | sct | ||
| hl7.fhir.us.resp-net | R4 | resp-net-negative-result-codes | resp-net-negative-result-codes | draft | 2025-08 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3242 | Risk Factor (Flu) | active | 2009-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.877 | Detailed Ethnicity | active | 2008-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3032 | Notifiable Condition (Hepatitis) | active | 2008-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1019 | Non-paint lead source - hobby related | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7464 | Insect Repellant | active | 2016-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7759 | Medication (TB) | active | 2022-01 | rx tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7923 | Medication Treatment (STD) | active | 2020-01 | sct rx tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7351 | Lab Test Performed Modifier (NND) | active | 2014-12 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7462 | Prenatal Diagnostic Procedures | active | 2016-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1018 | Non Paint Lead Source | active | 2008-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7447 | Nationally Notifiable Event Code (Generic) | active | 2019-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7276 | Nationally Notifiable Event Code (STD) | active | 2020-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1015 | Nationally Notifiable Disease Surveillance System (NNDSS) & Other Conditions of Public Health Importance | active | 2021-12 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1016 | Nationally Notifiable Infectious Disease reportable to the Nationally Notifiable Disease Surveillance System | active | 2016-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3589 | Observation Identifier (Syndromic Surveillance) | active | 2017-01 | oid loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3000 | PHLIP Questions (Flu) | active | 2014-01 | oid loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3245 | Radiology Lab Test (Flu) | active | 2009-01 | loinc | |||
| hl7.fhir.us.davinci-crd | R4 | DocReason | CRD Coverage Information Documentation Reason Value Set | trial-use | 1 | fm | 2025-08 | hl7 | fhir tho |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.834 | Allergen | active | 2008-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3246 | Specimen (Flu) | active | 2009-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7488 | Specimen Type (Arbovirus) | active | 2016-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7653 | Specimen Type (CRS) | active | 2017-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7841 | Specimen Type (Lyme) | active | 2019-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7657 | Specimen Type (Rubella) | active | 2017-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7463 | Specimen Type (Zika) | active | 2016-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7885 | Public Site of Exposure (CO) | active | 2019-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7896 | Residential Site of Exposure (CO) | active | 2019-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7784 | Diet Type (Listeria) | active | 2018-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7995 | Diet Type (Anthrax) | active | 2020-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3270 | Therapy 7 Days Prior or After Illness Onset (Pediatric Flu) | active | 2009-01 | tho | |||
| rapportendoscopiequebec.test | R4 | ca-qc-endo-valueset-villeendo | VilleEndo | active | 2024-05 | hl7 | |||
| rapportendoscopiequebec.test | R4 | ca-qc-endo-valueset-voieadministrationendo | VoieAdministrationEndo | active | 2024-05 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7801 | Signs and Symptoms (Listeria) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7817 | Type of Dairy Product (Listeria) | active | 2018-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7782 | Deli Meats (Listeria) | active | 2018-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7783 | Deli Salads (Listeria) | active | 2018-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7789 | Fruit (Listeria) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7792 | Illness (Listeria) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7786 | Food (Listeria) | active | 2018-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7796 | Patient Type (Listeria) | active | 2018-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7785 | Extended Race Group (Listeria) | active | 2018-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7805 | Yes No None (Listeria) | active | 2018-01 | sct tho | |||
| hl7.fhir.us.registry-protocols | R4 | Antiarrhythmics | All Antiarrhythmics | active | cic | 2023-11 | hl7 | rx | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3308 | Complications (Malaria) | active | 2017-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3268 | Acute Illness Complications (Pediatric Flu) | active | 2009-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3269 | Underlying Conditions (Pediatric Flu) | active | 2009-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3311 | Medication Prophylaxis (Malaria) | active | 2019-01 | rx tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3312 | Medication Treatment (Malaria) | active | 2019-01 | sct rx tho | |||
| hl7.fhir.us.pq-cmc-fda | R5 | cmc-specification-types-vs | Specification Section Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | tho |
| ca.on.dhdr.r4.v4 | R4 | accdr-vs-location-physical-type | Location Physical Type | active | hl7 | tho | |||
| hl7.fhir.us.registry-protocols | R4 | LocationInGraft | Location in the CABG Graft | active | cic | 2023-11 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8009 | Exposure Location (Brucellosis) | active | 2020-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7988 | Location Type (Leptospirosis) | active | 2020-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7797 | Birth Location (Listeria) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1052 | Transmission Setting (NND) | active | 2015-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3201 | Geographical location history | active | 2009-01 | iso tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3209 | Exposure Location | active | 2009-01 | sct tho oid | |||
| hl7.fhir.us.registry-protocols | R4 | ValvularStenosis | Valvular Stenosis | active | cic | 2023-11 | hl7 | loinc | |
| hl7.fhir.us.breast-radiology | R4 | LymphNodeAbnormalityTypeVS | Lymph Node Type ValueSet | active | 2022-12 | hl7 | fhir | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1007 | Major Site of Disease (TB) | active | 2008-01 | sct tho oid | |||
| hl7.fhir.us.registry-protocols | R4 | CABGType | Coronary Artery Bypass Graft Type | active | cic | 2023-11 | hl7 | fhir sct | |
| hl7.fhir.us.registry-protocols | R4 | StentType | CathPCI List of Stent Types | active | cic | 2023-11 | hl7 | sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3152 | Whole Cell ELISA Manufacturer (VZ) | active | 2008-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3153 | gp ELISA Manufacturer (VZ) | active | 2008-01 | tho | |||
| fhir.mamaToto | R4 | maritalStatusVS | Marital Status | draft | 2025-06 | hl7 | internal | ||
| fhir.r4.wales.test | R4 | DataStandardsWales-MaritalStatus | Data Standards Wales Marital Status | active | 2023-08 | hl7 | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.1.11.12212 | Marital Status Value Set | active | 2009-01 | tho | |||
| signal.core.r4 | R4 | questionnaire-ccars-marital-status | Questionnaire CCARS Marital Status | draft | 1 | pa | hl7 | ||
| hl7.fhir.us.spl | R5 | valueset-splMarketingStatuses | SPL Marketing Statuses ValueSet | trial-use | 1 | brr | 2025-07 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7848 | Exposure Setting Master (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7845 | Serotype Master (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7846 | Lab Test Interpretation Master (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7847 | Lab Test Type Master (RIBD) | active | 2018-01 | oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1138.564 | CABG or PCI Procedure | active | 2025-02 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1138.565 | CABG or PCI Procedure | active | 2025-01 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1138.566 | CABG or PCI Procedure | active | 2018-08 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.11.1007 | HIV 1 | active | 2024-11 | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3126 | Genotype (Measles) | active | 2008-01 | sct tho | |||
| hl7.fhir.us.davinci-vbpr | R4 | vbp-measure-population | VBP Measure Population Type | trial-use | 1 | cqi | 2025-07 | hl7 | fhir tho |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7669 | Food Processing Method (Trich) | active | 2018-01 | tho oid | |||
| hl7.fhir.us.registry-protocols | R4 | MechanicalVentricularSupportTiming | Mechanical Ventricular Support Timing | active | cic | 2023-11 | hl7 | fhir | |
| hl7.fhir.us.icsr-ae-reporting | R4 | MedDRATransfusionAdverseEventVS | Transfusion-related Adverse Events | draft | 2023-08 | hl7 | |||
| hl7.fhir.us.icsr-ae-reporting | R4 | MedDRAVaccinationAdverseEventVS | Vaccination-related Adverse Events | draft | 2023-08 | hl7 | |||
| signal.core.r4 | R4 | questionnaire-ccars-rae-aso-identification-codes | Questionnaire CCARS RAE ASO Identification Codes | draft | 1 | pa | hl7 | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7636 | Medical History (FDD) | active | 2017-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7795 | Medical History (Listeria) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.916 | Medical Specialty (HL7) | active | 2008-01 | tho | |||
| hl7.fhir.us.pacio-adi | R4 | ADIDMedicallyAssistedHydrationNutritionOrderGroupingVS | Medically Assisted Hydration Order Grouping | trial-use | 2 | pe | 2025-08 | hl7 | |
| hl7.fhir.us.pacio-adi | R4 | ADIDMedicallyAssistedHydrationNutritionOrderVS | Medically Assisted Hydration Order | trial-use | 2 | pe | 2025-08 | hl7 | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7932 | Duration Units (STD) | active | 2020-01 | ucum tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7931 | Medication Frequency Unit (STD) | active | 2020-01 | ucum sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7635 | Medication Administered (FDD) | active | 2017-01 | rx tho | |||
| fhir.cdc.opioid-cds-r4 | R4 | methadone-medications | Methadone medications | active | 2025-02 | hl7 | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8024 | Medication Completed (Brucellosis) | active | 2021-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7972 | Medication (Brucellosis) | active | 2020-01 | rx tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7839 | Medication Received (Lyme) | active | 2018-01 | rx tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3147 | Medication Received (VZ) | active | 2008-01 | rx tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.183 | Findings Related to Medication Management, Medication related | active | 2021-03 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7929 | Medication Route (STD) | active | 2020-01 | sct tho | |||
| fhir.cdc.opioid-cds-r4 | R4 | cns-depressant-medications | CNS depressant medications | active | 2025-02 | hl7 | |||
| fhir.cdc.opioid-cds-r4 | R4 | non-synthetic-opioid-medications | Non-synthetic opioid medications | active | 2025-02 | hl7 | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7710 | Medication Pre-Treatment (RIBD) | active | 2018-01 | sct tho | |||
| signal.core.r4 | R4 | questionnaire-ccars-history-of-mental-health-services | Questionnaire CCARS History Of Mental Health Services | draft | 1 | pa | hl7 | ||
| hl7.fhir.us.dme-orders | R4 | PAOx-Message-Event | PAO Message Event | draft | 2023-06 | hl7 | fhir | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.15 | MetabolicSyndromeCondition | active | 2025-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.9 | Metabolic Syndrome ICD10 | active | 2025-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.12 | Metabolic Syndrome LOINC | active | 2025-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.33 | Metastatic Breast Cancer | active | 2023-09 | hl7 | sct | ||
| hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-respiratory-motion-management-vs | Radiotherapy Respiratory Motion Management Value Set | active | cgp | 2025-02 | hl7 | sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7698 | Gestational Age Determination (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7199 | Detection Method (STD) | active | 2020-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7696 | Detection Method (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7671 | Food Cooking Method (Trich) | active | 2018-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3083 | Food Cooking Method (FDD) | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7930 | Route of Administration (STD) | active | 2020-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3084 | Food Processing Method (FDD) | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7727 | Titer Test Method (RIBD) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3142 | Test Method EIA IgM | active | 2008-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7105 | VPD Specimen Collection Method | active | 2020-01 | sct | |||
| hl7.cda.us.eyecare | R5 | RefractionMethodCodes | Refraction Method Codes | draft | 2024-02 | hl7 | sct | ||
| hl7.cda.us.eyecare | R5 | VisualAcuityMethodCodes | Visual Acuity Method Codes | draft | 2024-02 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3257 | Surveillance Method (Novel Flu) | active | 2009-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1009 | Microorganism | active | 2019-12 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7200 | Lab Results (STD) | active | 2020-01 | sct | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.49 | MSI Testing | active | 2023-11 | hl7 | loinc | ||
| hl7.fhir.us.military-service | R4 | military-service-branch-vs | Military Branch Value Set | active | 2023-05 | hl7 | fhir | ||
| hl7.fhir.us.military-service | R4 | military-service-military-occupation-vs | Military Occupation Value Set | active | 2023-05 | hl7 | fhir | ||
| hl7.fhir.us.directory-query | R4 | MinEndpointConnectionTypeVS | Minimum Endpoint Connection Types Value Set | active | 2022-12 | hl7 | fhir tho | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | MinEndpointConnectionTypeVS | Minimum Endpoint Connection Types VS | trial-use | fm | 2025-02 | hl7 | fhir tho | |
| hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-image-guided-radiotherapy-modality-vs | Image Guided Radiotherapy Modality Value Set | active | cgp | 2025-02 | hl7 | sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7684 | Mode of Delivery (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3107 | Travel Mode | active | 2008-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7765 | Molecular Indel (TB) | active | 2017-12 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7766 | Molecular Test Methods (TB) | active | 2017-12 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7764 | Molecular Test Results (TB) | active | 2017-12 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7165 | Previous Cesarean (NCHS) | active | 2014-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7218 | Syphilis Clinical Stage (CS) | active | 2020-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8046 | Mother Nucleic Acid Test Result (Perinatal Hep) | active | 2021-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7222 | Serologic Response (CS) | active | 2020-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7219 | Syphilis Surveillance Stage (CS) | active | 2019-12 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7768 | Moved Where During Therapy (TB) | active | 2017-12 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7808 | N. meningitidis Serogroup (RIBD) | active | 2020-01 | sct tho oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.112 | Chronic kidney disease I10 | active | 2023-09 | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.520.4.16 | NAACCR ICD-9-CM Cancer Reportability List | active | 2012-01 | fhir | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.28 | Her2 Negative | active | 2023-09 | hl7 | ncit | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6006 | Legacy Reporting Jurisdiction (CDS) | active | 2011-01 | oid | |||
| fhir.org.nz.ig.base | R4 | nhi-use | Valid use values for NHI | active | 2025-06 | hl7 | fhir | ||
| fhir.r4.nhsengland.programme | R4 | England-ObservationCode | England Observation Code | draft | 2024-12 | hl7 | sct | ||
| fhir.r4.nhsengland.programme | R4 | England-ObservationValueCode | England Observation Value Code | draft | 2024-12 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.89 | Maternal Diagnoses | active | 2023-10 | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.13.19 | Healthcare Service Location (NHSN) | active | 2017-12 | cdc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3380 | Substance Refusal Reason (IIS) | active | 2010-01 | oid |
FHIR